TRMED Relative Valuation - Thor Medical ASA - Alpha Spread
T

Thor Medical ASA
OSE:TRMED

Watchlist Manager
Thor Medical ASA
OSE:TRMED
Watchlist
Price: 1.018 NOK 0.79% Market Closed
Market Cap: 239.1m NOK
Have any thoughts about
Thor Medical ASA?
Write Note

Relative Value

The Relative Value of one TRMED stock under the Base Case scenario is 0.029 NOK. Compared to the current market price of 1.018 NOK, Thor Medical ASA is Overvalued by 97%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TRMED Relative Value
Base Case
0.029 NOK
Overvaluation 97%
Relative Value
Price
T
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
7
vs Industry
9
Median 3Y
0
Median 5Y
0
Industry
7.7
vs History
vs Industry
Median 3Y
-2.7
Median 5Y
-3.1
Industry
23.9
Forward
-1
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-3.3
Industry
22.2
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-3.2
Industry
24
vs History
88
vs Industry
62
Median 3Y
1.8
Median 5Y
3.9
Industry
2.5
vs History
6
vs Industry
8
Median 3Y
0
Median 5Y
0
Industry
7.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.5
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.5
Industry
5.1
Forward
-1.6
vs History
vs Industry
Median 3Y
-2
Median 5Y
-2.4
Industry
4.7
Forward
-1.5
vs History
vs Industry
Median 3Y
-2.2
Median 5Y
-2.5
Industry
6.6
vs History
vs Industry
Median 3Y
-2.2
Median 5Y
-2.5
Industry
4.7
vs History
60
vs Industry
62
Median 3Y
0.7
Median 5Y
7.1
Industry
4.7

Multiples Across Competitors

TRMED Competitors Multiples
Thor Medical ASA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Thor Medical ASA
OSE:TRMED
237.7m NOK 297.2 -4.6 -5.7 -5.6
US
Abbvie Inc
NYSE:ABBV
341.9B USD 6.2 64.6 15.8 24.1
US
Amgen Inc
NASDAQ:AMGN
180.5B USD 5.8 57.7 20.2 36.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
129B USD 9.6 29.8 26.2 29
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.6B USD 12 -252.2 26.8 28.2
US
Gilead Sciences Inc
NASDAQ:GILD
104.5B USD 3.8 99.3 9.4 12
US
Epizyme Inc
F:EPE
94.1B EUR 1 981.8 -505.7 -550.7 -536
AU
CSL Ltd
ASX:CSL
142.3B AUD 6.5 36.7 22.4 28
US
Seagen Inc
F:SGT
39.3B EUR 19.1 -58.5 -63 -56.9
US
Palatin Technologies Inc
LSE:0KF3
38.5B USD 6 513.5 -1 169.6 -1 185.3 -1 173.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
35.4B USD 15.1 -485.3 213.7 328.9
P/E Multiple
Earnings Growth
NO
T
Thor Medical ASA
OSE:TRMED
Average P/E: 57.6
Negative Multiple: -4.6
N/A
US
Abbvie Inc
NYSE:ABBV
64.6
406%
US
Amgen Inc
NASDAQ:AMGN
57.7
74%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29.8
56%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -252.2
38%
US
Gilead Sciences Inc
NASDAQ:GILD
99.3
71%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -505.7 N/A
AU
CSL Ltd
ASX:CSL
36.7
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.5 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 169.6 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -485.3 N/A
EV/EBITDA Multiple
EBITDA Growth
NO
T
Thor Medical ASA
OSE:TRMED
Average EV/EBITDA: 47.8
Negative Multiple: -5.7
N/A
US
Abbvie Inc
NYSE:ABBV
15.8
28%
US
Amgen Inc
NASDAQ:AMGN
20.2
57%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
26.2
47%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.8
39%
US
Gilead Sciences Inc
NASDAQ:GILD
9.4
10%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -550.7 N/A
AU
CSL Ltd
ASX:CSL
22.4
45%
US
S
Seagen Inc
F:SGT
Negative Multiple: -63 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 185.3 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
213.7
N/A
EV/EBIT Multiple
EBIT Growth
NO
T
Thor Medical ASA
OSE:TRMED
Average EV/EBIT: 69.5
Negative Multiple: -5.6
N/A
US
Abbvie Inc
NYSE:ABBV
24.1
86%
US
Amgen Inc
NASDAQ:AMGN
36.6
95%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29
49%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.2
38%
US
Gilead Sciences Inc
NASDAQ:GILD
12
26%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -536 N/A
AU
CSL Ltd
ASX:CSL
28
59%
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.9 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 173.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
328.9
N/A

See Also

Discover More
Back to Top